Description
Emoxipin Pharmacodynamics
Emoxipin reduces capillary permeability, strengthens the vascular wall, stabilizes the cell membrane, inhibits platelet aggregation, reduces blood clotting and viscosity, has anti-aggregation and anti-hypoxic effect.
Indications
-Treatment and prevention of corneal inflammation and burns;
-Treatment of hemorrhages in the anterior chamber of the eye;
-Treatment and prophylaxis of sclera hemorrhages in elderly persons;
-Thrombosis of the central vein of the retina and its branches;
-Treatment of myopia complications;
-Diabetic retinopathy.
Contraindications
Individual hypersensitivity to the components of the drug, pregnancy, breast-feeding, children under 18 years of age.
Dosage and administration
- The drug is put into the conjunctival cavity, 1-2 drops 2-3 times a day.
- The duration of the course of treatment depends on the course of the disease (usually 3-30 days) and is determined by the doctor.
- In the presence of indications and good tolerance of the drug treatment course may be continued up to 6 months or repeated 2-3 times a year.
- INSTRUCTIONS FOR USE OF THE CAP DROPPER
1. Remove the aluminum cap and rubber stopper from the bottle, using scissors.
2. Put the polyethylene cap cap on the bottle, which is included in the bottle, having previously removed the packaging.
3. Turn the bottle upside down and drip drops by pressing the body of the dropper cap.
4. Close the dropper cap with the small cap by tearing off the three flaps at the bottom of the dropper cap.